Again, wtf are you talking about. We will easily hit $2.00 organically. What are you even basing that statement off of.
It’s amazing the amount of crap you spew out just for the sake of trying to sound relevant. For months you’re saying - no rise in pps until we go to nasdaq, yet here we are.
I’m not sure who puts you up to saying all this crap.
I thought $5 was for initial listing and $2 was the floor for continual listing. Unless we have absolutely explosive growth propelling forward multiples into the clouds, organic is unlikely.
One thing that he mentioned during call made me wonder if we will get first to file for oxy or just be among the first. On flip side Nasrat also clarified GDUFA estimated dates for all, except oxy. FDA hasn’t reached out for our oxy filing yet and if we had a Q1 GDUFA I would think FDA would be all over it. I’m not sure the partial filing bought us any favorable timing. Would be nice, but this may not have any financial impact until late calendar year 2024/early 2025.
Anyone pick up on clear GDUFA date guidance for oxy?